1. Is there a pharmacological basis for differences in 5-HT₃-receptor antagonist efficacy in refractory patients?

   • Ronald de Wit
   • Matti Aapro
   • Peter R Blower

   Review 19 April 2005 Pages: 231 - 238

   

2. Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft models

   • Christopher M. K. Springate
   • John K. Jackson
   • Helen M. Burt

   Original Article 30 April 2005 Pages: 239 - 247

   

3. P450 induction alters paclitaxel pharmacokinetics and tissue distribution with multiple dosing

   • Daniel L. Gustafson
   • Michael E. Long
   • Patrick J. Kerzic

   Original Article 27 April 2005 Pages: 248 - 254

   

4. Preclinical pharmacology of epothilone D, a novel tubulin-stabilizing antitumor agent

   • Hui Wang
   • Zhi Wang
   • Donald L. Hill

   Original Article 03 May 2005 Pages: 255 - 260

   

5. Structure-activity relationships of antineoplastic ring-substituted ether phospholipid derivatives

   • Panagiota Papazafiri
   • Nicolaos Avlonitis
   • Irene Fragiadaki

   Original Article 26 April 2005 Pages: 261 - 270

   

6. Genistein-induced apoptosis via Akt signaling pathway in anaplastic large-cell lymphoma

   • Sung-Shin Park
   • Yong-Nyun Kim
   • Chul Woo Kim

   Original Article 10 May 2005 Pages: 271 - 278

   

7. In vitro sequence-dependent interaction between nedaplatin and paclitaxel in human cancer cell lines

   • Risa Tanaka
   • Yasushi Takii
   • Shuji Nakano

   Original Article 04 May 2005 Pages: 279 - 285

   

8. Potential for drug interactions in hospitalized cancer patients

   • Rachel Pimenta Riechelmann
   • Frederico Moreira
   • Everardo D. Saad

   Original Article 25 February 2005 Pages: 286 - 290

9. Preclinical pharmacology of 2-methoxyantimycin A compounds as novel antitumor agents

   • Hui Wang
   • Mao Li
   • Donald L. Hill

   Original Article 10 May 2005 Pages: 291 - 298

   

10. Metabolism of docetaxel in mice

    • Heleen A. Bardelmeijer
    • Arjan B. G. H. Roelofs
    • Olaf van Tellingen

    Original Article 30 April 2005 Pages: 299 - 306

    

11. Effect of NQO1 induction on the antitumor activity of RH1 in human tumors in vitro and in vivo

    • Tyler Digby
    • Marsha K. Leith
    • Asher Begleiter

    Original Article 05 May 2005 Pages: 307 - 316

    

12. Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma

    • Kevin T. Murphy
    • Abdullah Wardak
    • Helena J. Mauceri

    Original Article 11 May 2005 Pages: 317 - 321

    

13. Effects and interaction of 7-hydroxy methotrexate and methotrexate in leukaemic cells ex vivo measured by the thymidylate synthase inhibition assay

    • R. M. Lingg
    • G. Hempel
    • G. J. L. Kaspers

    Short Communication 03 May 2005 Pages: 322 - 327